Skip to main content

$0.005 (0%)

High

$0.01

Low

$0.00

Trades

68

Turnover

$72,477

Volume

14,697,042
30 June 2023 at 4:10pm
Register to track MXC and receive email alerts.
Subject
MXC Ann: s708A(5)(e) Cleansing Notice

MXC Ann: Application for quotation of securities - MXC

MXC Ann: s708A(5)(e) Cleansing Notice

MXC Ann: Application for quotation of securities - MXC

MXC Ann: Application for quotation of securities - MXC

MXC Ann: ARTEMIC EU SALE APPROVAL AND CLINICAL TRIAL UPDATE

MXC Ann: UK IMPORT PERMIT GRANTED FOR CANNEPIL

MXC Ann: Update - Notification of cessation of securities - MXC

MXC Ann: Update - Application for quotation of securities - MXC

MXC Ann: s708(5)(e) Cleansing Notice

MXC Ann: Appendix 3Y x 6

MXC Ann: Notification regarding unquoted securities - MXC

MXC Ann: Notification of cessation of securities - MXC

MXC Ann: Application for quotation of securities - MXC

MXC Ann: CIMETRA IMPORT APPROVAL GRANTED FOR INDIA

MXC Ann: Preliminary Final Report

MXC Ann: Proposed issue of securities - MXC

MXC Ann: Information on expiring options

MXC Ann: MGC PHARMA EXECUTES US$24M US SUPPLY AGREEMENT

MXC Ann: Results of General Meeting

MXC Ann: General Meeting Web Cast Facility

MXC Ann: Notice to Holders of Expiring Options

MXC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

MXC Ann: Response to ASX Query Letter

MXC Ann: Amendment to Appendix 3H lodged 13 July 2021

MXC Ann: PATENT APPLICATION LODGED FOR NOVEL DRUG DELIVERY SYSTEM

MXC Ann: Notification of cessation of securities - MXC

MXC Ann: s708A(5)(e) Cleansing Notice - Issue of Shares

MXC Ann: Application for quotation of securities - MXC

MXC Ann: 1ST PATIENT RECRUITED INTO CIMETRA PHASE 3 CLINICAL TRIAL

MXC Ann: Cleansing Notice on Issue of Shares

MXC Ann: Application for quotation of securities - MXC

MXC Ann: Notice of General Meeting/Proxy Form

MXC Ann: CANNEPIL AVAILABLE FOR FREE DISPENSING IN IRELAND

MXC Ann: Issue of shares and resignation of Company Secretary

MXC Ann: Application for quotation of securities - MXC

MXC Ann: Application for quotation of securities - MXC

MXC Ann: Proposed issue of securities - MXC

MXC Ann: Company Secretary Appointment

MXC Ann: MGC PHARMA 2021 CLINICAL TRIALS PROGRAM UPDATE

MXC Ann: CIMETRA PATENT SUBMITTED TO EUROPEAN IP OFFICE

MXC Ann: Appendix 3G x 3

MXC Ann: Appendix 2A

MXC Ann: FURTHER FINDINGS ON ARTEMIC AS ANTI-INFLAMMATORY AGENT

MXC Ann: Trading Halt

MXC Ann: Pause in Trading

MXC Ann: $1M ORDER FOR ARTEMIC RESCUE FROM SWISS PHARMACAN

MXC Ann: ARTEMIC SUBMITTED TO HEALTH CANADA

MXC Ann: MARCH QUARTERLY ACTIVITY AND CASHFLOW REPORT

MXC Ann: Proposed issue of Securities - MXC

Register to track MXC and receive email alerts.

Similar Companies

CAN
CPH
EOF
IHL
MVP
MYX
NEU
PBP
RCE
SPL